Atlas FDA

ColoSense

FDA premarket approval P230001/S006 · decided 2024-10-16

Approval details

PMA number
P230001
Supplement
S006
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
ColoSense
Generic name
System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection
Applicant
Geneoscopy, Inc.
Date received
2024-09-17
Decision date
2024-10-16
Days to decision
29 days
Decision code
OK30
Product code
SBB
Advisory committee
Pathology
Expedited review
No
Location
St. Louis, MO
Statement
Improvement changes to the HVAC system of the firm's pre-amplification room

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.